Global Nocturia Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Nocturia, also known as nocturnal polyuria, is a medical condition in which patients get a frequent urge to urinate while sleeping at night. It is particularly prevalent among the elderly who often find it difficult to sleep properly. The three broad categories of nocturia are mixed nocturia, bladder storage problems, and nocturnal polyuria.
According to our (Global Info Research) latest study, the global Nocturia market size was valued at US$ 2351 million in 2023 and is forecast to a readjusted size of USD 3709 million by 2030 with a CAGR of 6.8% during review period.
Global core nocturia manufactures include Astellas Pharma, Allergan, Eli Lilly etc. The top 2 companies hold a share about 30%. North America is the largest market, with a share about 40%, followed by Europe and Asia Pacific with the share about 34% and 18%. In terms of product, alpha blockers is the largest segment, with a share over 37%.
This report is a detailed and comprehensive analysis for global Nocturia market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Sale Channels. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Nocturia market size and forecasts, in consumption value ($ Million), 2019-2030
Global Nocturia market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Nocturia market size and forecasts, by Type and by Sale Channels, in consumption value ($ Million), 2019-2030
Global Nocturia market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nocturia
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nocturia market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Astellas Pharma, Allergan, Ferring Pharmaceuticals, Eli Lilly, GlaxoSmithKline, Sanofi, Pfizer, Abbott, Teva, Mylan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Nocturia market is split by Type and by Sale Channels. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Sale Channels. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Nocturia market is split by Type and by Sale Channels. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Sale Channels. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Desmopressin
Anticholinergic Drugs
Alpha Blockers
Diuretics
Others
Market segment by Sale Channels
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by players, this report covers
Astellas Pharma
Allergan
Ferring Pharmaceuticals
Eli Lilly
GlaxoSmithKline
Sanofi
Pfizer
Abbott
Teva
Mylan
Johnson & Johnson
Hainan Zhonghe Pharmaceutical
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Nocturia product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nocturia, with revenue, gross margin, and global market share of Nocturia from 2019 to 2024.
Chapter 3, the Nocturia competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Sale Channels, with consumption value and growth rate by Type, by Sale Channels, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Nocturia market forecast, by regions, by Type and by Sale Channels, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nocturia.
Chapter 13, to describe Nocturia research findings and conclusion.